NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · IEX Real-Time Price · USD
9.27 -0.02 (-0.22%)
Jan 25, 2022 4:00 PM EST - Market closed
Market Cap225.39M
Revenue (ttm)44.94M
Net Income (ttm)-30.01M
Shares Out24.31M
EPS (ttm)-2.75
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,918
Open9.34
Previous Close9.29
Day's Range9.25 - 9.62
52-Week Range8.29 - 27.38
Betan/a
AnalystsBuy
Price Target19.40 (+109.3%)
Earnings Daten/a

About NPCE

NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. w...

IndustryMedical Devices
IPO DateApr 22, 2021
Employees165
Stock ExchangeNASDAQ
Ticker SymbolNPCE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for NeuroPace stock is "Buy." The 12-month stock price forecast is 19.40, which is an increase of 109.28% from the latest price.

Price Target
$19.40
(109.28% upside)
Analyst Consensus: Buy

News

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) --  NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, t...

2 weeks ago - GlobeNewsWire

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

1 month ago - GlobeNewsWire

NeuroPace Reports Third Quarter 2021 Financial Results

MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

2 months ago - GlobeNewsWire

NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy

IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation  to treat primary generalized epilepsy in patients aged 12 and older

2 months ago - GlobeNewsWire

NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021

MOUNTAIN VIEW, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

3 months ago - GlobeNewsWire

NeuroPace Announces Addition of Lisa Andrade to the Board

MOUNTAIN VIEW, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc., (Nasdaq:NPCE) a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announce...

3 months ago - GlobeNewsWire

NeuroPace to Participate in Upcoming Conferences

MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

5 months ago - GlobeNewsWire

NeuroPace Reports Second Quarter 2021 Financial Results

MOUNTAIN VIEW, Calif. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, t...

5 months ago - GlobeNewsWire

NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Informa...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (NASDAQ: NPCE), a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announced the broad laun...

5 months ago - Business Wire

NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021

MOUNTAIN VIEW, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

6 months ago - GlobeNewsWire

Could This Recently IPOed Medical Device Maker Make You Rich?

Small-cap epilepsy treatment specialist NeuroPace looks a lot like Abiomed did in its early days.

6 months ago - The Motley Fool

NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Sy...

Feasibility IDE study will be the first to evaluate responsive neuromodulation for a severe and disabling childhood-onset epilepsy

6 months ago - GlobeNewsWire

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, to...

7 months ago - GlobeNewsWire

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, tod...

8 months ago - GlobeNewsWire

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchas...

MOUNTAIN VIEW, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of pat...

8 months ago - GlobeNewsWire

NeuroPace, Inc. Announces Pricing of Initial Public Offering

MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of pat...

9 months ago - GlobeNewsWire

Let's Take a Look At Some Upcoming IPOs This Week

There have been quite a few appealing Initial Public Offerings (IPOs) available on the market so far this year. Here are some upcoming IPOs that investors should be watching out for.

Other symbols:PATHSKYTSWIMZY
9 months ago - Benzinga